Sparsentan cut proteinuria about 70% and kept kidney function stable over 2 years in newly diagnosed IgA nephropathy in the SPARTAN study.
In 2024, Medicare Advantage insurers denied 7.7% of nearly 53 million prior authorization requests, and 80.7% of the 11.5% of denials appealed were overturned. Speakers at ASN Kidney Week urge ...
Weekly initiation of oral semaglutide among US adults eligible for obesity medications rose from nearly 0 to a peak of 4.56 ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for ...
Incidence of major adverse cardiovascular events (MACE) declined across every income group in Denmark from 1988 to 2023, but ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
Hiddo J. Heerspink, PhD, is a professor of clinical trials and personalized medicine at University Medical Center Groningen in the Netherlands.
Hiddo Heerspink, PhD, discusses finerenone data in type 1 diabetes, FSGS and IgA nephropathy, and open questions on sequencing CKD therapies. Finerenone (Kerendia; Bayer) is showing kidney-protective ...
The uninsured rate among US adults aged 19 to 64 years rose from 8.9% in 2024 to 11.2% in 2026, a statistically significant ...
People with arrhythmogenic cardiomyopathy (ACM) may face increased risk of ventricular arrhythmias and worsening heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results